The Week In Review: Should you sell your shares in Marks & Spencer?

Marks & Spencer is extending its returns policy to its shares. It is to spend a whopping £2.3bn buying back 29 per cent of its share capital. Marks is returning the money via a tender offer to buy shares at between 332p and 380p - the eventual strike price will depend on what volume of shares is tendered at what level. You have until 11am on 20 October to decide.

So, should you sell? It all depends on how much faith you have in Stuart Rose, the new chief executive. Considering the enormity of Marks' woes, even Mr Rose is unlikely to make a difference until well into next year. Meanwhile the consumer environment is deteriorating.

Given that this column tipped M&S in January as its retail stock of the year, if you listened then, it might be wise to tender some of your holding at a lowish level to lock in some profit.

If you are a long-term investor, however, even the tender offer looks laughable and you are probably already nursing a loss. So hang on for Mr Rose's back to basics campaign to pay off. "Your M&S" still has something going for it after all - otherwise why would Mr Green have offered 400p per share?

Better ranges will help, as will the re-focus on its core, older customer base. Sexy it ain't, but given its heritage, M&S is definitely here to stay.


An extra £1.2bn has landed in the coffers at Diageo, the global drinks giant whose brands include Guinness, Baileys, Johnnie Walker whisky, Gordon's gin and Smirnoff vodka. The group has sold two-thirds of its stake in General Mills, a US food company. Diageo's is an impressive portfolio of global brands, augmented by an array of local market leaders and some growing wine brands as well. And since it already generates more cash than it can invest in its core business, more share buy-backs are on the cards. Hold.


Efes Brewing (EBI) is the international arm of a Turkish beer monopoly, headquartered in the Netherlands, and if all goes according to plan, will have a stock market listing in London this month. Its focus is premium lager in emerging markets. It makes most of its money in Russia, where beer drinking is growing but competition is tough. Not for the faint-hearted, but worth placing an order.


BTG, formed out of the old National Enterprise Board and privatised in 1995, invests in new technologies, adds its commercial nous to the projects, and then licenses them out again to corporate partners in return for one-off fees and royalties. It always has been a long-term investment, and there is no point bailing out now. The company's patent battles with Apple, Amazon and Microsoft might end with lucrative settlements. The stock could perk up.


What are Game shareholders going to get for Christmas this year? The computer games retailer makes all its profit over the festive period. Consoles should be a popular present since they have come right down in price, but the risk is that it will be the supermarket sales which turn them into a mass market product. There is also sure to be vicious price competition again on software. Game shares look cheap if you believe the company will deliver its earnings forecasts. But that's a bit like believing in Father Christmas.


Manganese Bronze, the black cab manufacturer, has failed to make a profit since 2000. The biggest driver of its losses continues to be Zingo - its fledgling mobile phone cab-hailing service, which locates its customers using Global Positioning Satellite technology. With so many Zingo customers having been left cab-less due to the small size of its fleet, it has an enormous job to win the support it needs. Sell.


Ted Baker likes to think of itself more as a "lifestyle" brand than mere clothing retailer. It is enjoying growth in all its divisions, in men's and women's clothing and across its own stores, franchises and wholesaling. In the US, Ted has proved a particular hit with the ladies. This column is a long-term Ted aficionado, but at current prices the shares are more of a hold than a buy.


The financial performance of Tottenham Hotspur, as we saw in their annual results, has been poor. Only the pre-tax profit line looked less sickly, since the previous year had been disfigured by the accounting effects of player sales, and losses reduced from £7.1m to £2.5m in the year to 30 June. It is off to a much better start this season, with the club lying fifth in the Premiership. It would be too early to start salivating over European competition but the mega-bucks that come with that sort of breakthrough would be swallowed up by increased player bonuses and wages. Which is as it should be, because football is not about making money, it is about trophies. Avoid.


In previous years, private nursing agencies have made fat margins supplying expensive temps to understaffed hospitals. Now, the NHS has organised its own in-house banks of supply nurses. The squeeze on Reed Health and its rivals will continue as the NHS hires more nurses, and spread to other areas of Reed's business, including local authority care. Avoid.


TBI, the regional airports group, owns Luton, Cardiff, Belfast and Skavsta in Sweden, where low-cost operators continued to drive growth in passenger numbers. Airlines, though, are battling with rising fuel prices and intense price competition, while increased flights at Luton will have no significant profit impact for four years because of deeply discounted landing charges and the concession fees TBI pays to local councils. Only hold

AstraZeneca shares a hold until political issues play out

A bit like the bumble bee, AstraZeneca shouldn't really have kept flying - but it has. When it was created in 1999 from an Anglo-Swedish merger, the drug giant was staring at the imminent loss of revenue from what was then the world's best selling drug, Losec, an ulcer pill with sales of £10m a day.

Well, the company kept Losec's copycat rivals tied up in the patent courts long enough to switch patients to a better version of the drug. That replacement, Nexium, is swatting away all the competitive threats to this day. Meanwhile, AstraZeneca has launched blockbuster after blockbuster and now has an impressive portfolio of drugs with plenty of growth in them

There have been disappointments. Crestor, an anti-cholesterol pill, probably won't meet its target of snatching 20 per cent of the global market for this type of drug. And it is going to take years to establish the safety of Exanta, a revolutionary blood-thinning drug whose launch was blocked by a US regulatory panel.

But sleeping giants are waking. Seroquel, for manic depression and schizophrenia, is establishing itself as a powerful tool for psychiatrists. Symbicort might be a serious player in the competitive asthma market. And AstraZeneca looks like it may have one of most impressive portfolios of cancer drugs for the next decade.

Sir Tom McKillop, chief executive, set out some home truths this week: public trust in the industry is so low and healthcare costs so high that it is doomed to lose the coming battles over drug prices. In the US, the most lucrative drug market, prices will inevitably fall, so painful cost cuts will have to be made to keep operating profits growing.

AstraZeneca shares are not a buy while these political issues play out. We said "sell" a year ago at 2,630p, and several product setbacks we feared then have turned out true. Now, the risks are more evenly balanced. Hold.

The above is a selection from the daily Investment Column

Arts and Entertainment
Sheeran arrives at the 56th annual Grammy Awards earlier this year
musicYes, that would be Ed Sheeran, according to the BBC
Arts and Entertainment
AKB48 perform during one of their daily concerts at Tokyo’s Akihabara theatre
musicJapan's AKB48 are one of the world’s most-successful pop acts
Ian Thorpe has thanked his supporters after the athlete said in an interview that he is gay
The headstone of jazz great Miles Davis at Woodlawn Cemetery in New York
Arts and Entertainment
Brendan O'Carroll has brought out his female alter-ego Agnes Brown for Mrs Brown's Boys D'Movie
filmComedy holds its place at top of the UK box office
newsBear sweltering in zoo that reaches temperatures of 40 degrees
Arts and Entertainment
Professor Kathy Willis will showcase plants from the Royal Botanic Gardens at Kew
radioPlants: From Roots to Riches has been two years in the making
Arts and Entertainment
TV The follow-up documentary that has got locals worried
Arts and Entertainment
Eminem's daughter Hailie has graduated from high school
Arts and Entertainment
Original Netflix series such as Orange Is The New Black are to benefit from a 'substantial' increase in investment
TVHoax announcement had caused outrage
Life and Style
Swimsuit, £245, by Agent Provocateur

Diving in at the deep end is no excuse for shirking the style stakes

One Direction star Harry Styles who says he has no plans to follow his pal Cara Delevingne down the catwalk.
peopleManagement confirms rumours singer is going it alone are false
Finacial products from our partners
Property search
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

ES Rentals

    iJobs Job Widget
    iJobs Money & Business

    Information Security Manager (ISO 27001, Accreditation, ITIL)

    £70000 per annum: Harrington Starr: Information Security Manager (ISO 27001, A...

    Biztalk - outstanding opportunity

    £75000 - £85000 per annum + ex bens: Deerfoot IT Resources Limited: Biztalk Te...

    Trade Desk Specialist (FIX, Linux, Windows, Network Security)

    £60000 per annum: Harrington Starr: Trade Desk Specialist (FIX, Linux, Windows...

    Service Desk Analyst (Windows, Active Directory, ITIL, Reuter)

    £35000 per annum: Harrington Starr: Service Desk Analyst (Windows, Active Dire...

    Day In a Page

    Super Mario crushes the Messi dream as Germany win the 2014 World Cup in Brazil

    Super Mario crushes the Messi dream

    Germany win the 2014 World Cup in Brazil
    Saharan remains may be evidence of the first race war, 13,000 years ago

    The first race war, 13,000 years ago?

    Saharan remains may be evidence of oldest large-scale armed conflict
    Scientists find early warning system for Alzheimer’s

    Scientists find early warning system for Alzheimer’s

    Researchers hope eye tests can spot ‘biomarkers’ of the disease
    Sex, controversy and schoolgirl schtick

    Meet Japan's AKB48

    Pop, sex and schoolgirl schtick make for controversial success
    In pictures: Breathtaking results of this weekend's 'supermoon'

    Weekend's 'supermoon' in pictures

    The moon appeared bigger and brighter at the weekend
    Iraq crisis: How Saudi Arabia helped Isis take over the north of the country

    How Saudi Arabia helped Isis take over northern Iraq

    A speech by an ex-MI6 boss hints at a plan going back over a decade. In some areas, being Shia is akin to being a Jew in Nazi Germany, says Patrick Cockburn
    The evolution of Andy Serkis: First Gollum, then King Kong - now the actor is swinging through the trees in Dawn of the Planet of the Apes

    The evolution of Andy Serkis

    First Gollum, then King Kong - now the actor is swinging through the trees in Dawn of the Planet of the Apes
    You thought 'Benefits Street' was controversial: Follow-up documentary 'Immigrant Street' has got locals worried

    You thought 'Benefits Street' was controversial...

    Follow-up documentary 'Immigrant Street' has got locals worried
    Refugee children from Central America let down by Washington's high ideals

    Refugee children let down by Washington's high ideals

    Democrats and Republicans refuse to set aside their differences to cope with the influx of desperate Central Americas, says Rupert Cornwell
    Children's books are too white, says Laureate

    Children's books are too white, says Laureate

    Malorie Blackman appeals for a better ethnic mix of authors and characters and the illustrator Quentin Blake comes to the rescue
    Blackest is the new black: Scientists have developed a material so dark that you can't see it...

    Blackest is the new black

    Scientists have developed a material so dark that you can't see it...
    Matthew Barzun: America's diplomatic dude

    Matthew Barzun: America's diplomatic dude

    The US Ambassador to London holds 'jeans and beer' gigs at his official residence – it's all part of the job, he tells Chris Green
    Meet the Quantified Selfers: From heart rates to happiness, there is little this fast-growing, self-tracking community won't monitor

    Meet the 'Quantified Selfers'

    From heart rates to happiness, there is little this fast-growing, self-tracking community won't monitor
    Madani Younis: Five-star reviews are just the opening act for British theatre's first non-white artistic director

    Five-star reviews are just the opening act for British theatre's first non-white artistic director

    Madani Younis wants the neighbourhood to follow his work as closely as his audiences do
    Mrs Brown and her boys: are they having a laugh?

    Mrs Brown and her boys: are they having a laugh?

    When it comes to national stereotyping, the Irish – among others – know it can pay to play up to outsiders' expectations, says DJ Taylor